| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A bibliometric analysis of scientific production in mesothelioma research
|
Ugolini, Donatella
|
|
2010
|
70 |
2 |
p. 129-135
7 p.
|
artikel
|
| 2 |
Characterization of side population cells in human malignant mesothelioma cell lines
|
Kai, Kiyonori
|
|
2010
|
70 |
2 |
p. 146-151
6 p.
|
artikel
|
| 3 |
Clinical outcomes in extracranial tumor sites and unusual toxicities with concurrent whole brain radiation (WBRT) and Erlotinib treatment in patients with non-small cell lung cancer (NSCLC) with brain metastasis
|
Olmez, Inan
|
|
2010
|
70 |
2 |
p. 174-179
6 p.
|
artikel
|
| 4 |
Complex rather than vague
|
Vos, Martina S.
|
|
2010
|
70 |
2 |
p. 227-228
2 p.
|
artikel
|
| 5 |
Contents
|
|
|
2010
|
70 |
2 |
p. v-vi
nvt p.
|
artikel
|
| 6 |
Copy number alterations and expression profiles of candidate genes in a pulmonary inflammatory myofibroblastic tumor
|
Jung, Seung-Hyun
|
|
2010
|
70 |
2 |
p. 152-157
6 p.
|
artikel
|
| 7 |
Corrigendum to “Cost-effectiveness analysis of bevacizumab versus pemetrexed for advanced non-squamous NSCLC in Italy” [Lung Cancer 69S1 (2010) S11–S18]
|
|
|
2010
|
70 |
2 |
p. 231-
1 p.
|
artikel
|
| 8 |
Corrigendum to “Effectiveness of bevacizumab- and pemetrexed-cisplatin treatment for patients with advanced non-squamous non-small cell lung cancer” [Lung Cancer 69S1 (2010) S4–S10]
|
|
|
2010
|
70 |
2 |
p. 230-
1 p.
|
artikel
|
| 9 |
Dose-escalation study of pemetrexed in combination with carboplatin followed by pemetrexed maintenance therapy for advanced non-small cell lung cancer
|
Okamoto, Isamu
|
|
2010
|
70 |
2 |
p. 168-173
6 p.
|
artikel
|
| 10 |
Editorial Board
|
|
|
2010
|
70 |
2 |
p. iii-
1 p.
|
artikel
|
| 11 |
Efficacy of circulating plasma DNA as a diagnostic tool for advanced non-small cell lung cancer and its predictive utility for survival and response to chemotherapy
|
Kumar, Sachin
|
|
2010
|
70 |
2 |
p. 211-217
7 p.
|
artikel
|
| 12 |
Exercise interventions following surgery for non-small cell lung cancer (NSCLC): The need for future randomised controlled trials
|
Granger, C.
|
|
2010
|
70 |
2 |
p. 228-229
2 p.
|
artikel
|
| 13 |
Histology classification is not a predictor of clinical outcomes in advanced non-small cell lung cancer (NSCLC) treated with vinorelbine or gemcitabine combinations
|
Trani, L.
|
|
2010
|
70 |
2 |
p. 200-204
5 p.
|
artikel
|
| 14 |
Involved field radiotherapy for locally advanced non-small cell lung cancer: Isolated mediastinal nodal relapse
|
Vanneste, B.G.L.
|
|
2010
|
70 |
2 |
p. 218-220
3 p.
|
artikel
|
| 15 |
Involvement of LKB1 in epithelial–mesenchymal transition (EMT) of human lung cancer cells
|
Roy, Badal C.
|
|
2010
|
70 |
2 |
p. 136-145
10 p.
|
artikel
|
| 16 |
Maintenance or consolidation therapy in small-cell lung cancer: A systematic review and meta-analysis
|
Rossi, Antonio
|
|
2010
|
70 |
2 |
p. 119-128
10 p.
|
artikel
|
| 17 |
Phase I study of autologous dendritic cell tumor vaccine in patients with non-small cell lung cancer
|
Um, Soo-Jung
|
|
2010
|
70 |
2 |
p. 188-194
7 p.
|
artikel
|
| 18 |
Subcarinal lymph node in upper lobe non-small cell lung cancer patients: Is selective lymph node dissection valid?
|
Aokage, Keiju
|
|
2010
|
70 |
2 |
p. 163-167
5 p.
|
artikel
|
| 19 |
Successful treatment of two lung cancer patients with erlotinib following gefitinib-induced hepatotoxicity
|
Ku, Geoffrey Y.
|
|
2010
|
70 |
2 |
p. 223-225
3 p.
|
artikel
|
| 20 |
Sunitinib in combination with gemcitabine plus cisplatin for advanced non-small cell lung cancer: A phase I dose-escalation study
|
Reck, Martin
|
|
2010
|
70 |
2 |
p. 180-187
8 p.
|
artikel
|
| 21 |
Surgical resection of liver non-small cell lung cancer metastasis: A dual weapon?
|
Ileana, Ecaterina
|
|
2010
|
70 |
2 |
p. 221-222
2 p.
|
artikel
|
| 22 |
Surgical treatment of bronchial carcinoid tumors: A single-center experience
|
Machuca, Tiago Noguchi
|
|
2010
|
70 |
2 |
p. 158-162
5 p.
|
artikel
|
| 23 |
The immunohistochemical overexpression of ribonucleotide reductase regulatory subunit M1 (RRM1) protein is a predictor of shorter survival to gemcitabine-based chemotherapy in advanced non-small cell lung cancer (NSCLC)
|
Lee, Jae Jin
|
|
2010
|
70 |
2 |
p. 205-210
6 p.
|
artikel
|
| 24 |
Tumor histology affects the accuracy of clinical evaluative staging in primary lung cancer
|
Funakoshi, Yasunobu
|
|
2010
|
70 |
2 |
p. 195-199
5 p.
|
artikel
|
| 25 |
We should avoid vague conceptualisations and circular outcomes
|
Salander, Pär
|
|
2010
|
70 |
2 |
p. 226-
1 p.
|
artikel
|
Tijdschrift beschrijving